Literature DB >> 29773224

Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaques.

Jin Fan1, Hua Liang2, Tao Shen1, Shuo Wang2, Xiaolin Ji2, Cassian Yee3, Fengmin Lu4, Yiming Shao5.   

Abstract

Early immunological events in acute HIV infection are thought to fundamentally influence long-term disease outcomes. Though the contribution of Gag-specific CD8 T cell responses to early viral control is well established, little is known about the role of Env-specific CD8 T cell responses in controlling viral replication during acute infection. In a macaque simian-human immunodeficiency virus (SHIV) model, some macaques who were able to control SHIV replication after ART interruption showed expansion of Env-specific CD8 T cell responses during acute infection, compared to macaques who progressed to viral rebound. To better understand the function of early Env-specific CD8 T cells, we isolated, expanded and examined their ability to act as effectors in vitro. We observed that Env-specific CD8 T cell clones have the capacity to directly recognize and kill SHIV-infected CD4 T cells, but failed to reduce viral replication in SHIV-infected macrophages. Our data suggest that early Env-specific CD8 T cell responses during acute SHIV infection contribute substantially to the control of viral replication. The T-cell clones composing of Env-specific effector cells demonstrates in vitro phenotypic and functional characteristics with the potentials to provide longlasting clinical benefit of in vivo HIV study.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Acute infection; CTL; Env; Function; SHIV

Mesh:

Substances:

Year:  2018        PMID: 29773224     DOI: 10.1016/j.cellimm.2018.05.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques.

Authors:  Jin Fan; Hua Liang; Xiaolin Ji; Shuo Wang; Jing Xue; Dan Li; Hong Peng; Chuan Qin; Cassian Yee; Yiming Shao
Journal:  Nat Commun       Date:  2019-05-21       Impact factor: 14.919

Review 2.  New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection.

Authors:  Marisierra Espinar-Buitrago; Ma Angeles Muñoz-Fernández
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.